|Articles|January 1, 1999

January 1999
Volume 5
Issue 1

A Community Hospital-Based Congestive Heart Failure Program: Impact on Length of Stay, Admission and Readmission Rates, and Cost

Author(s)R. Andrew Rauh, MD, Nancy J. Schwabauer, RN, MS, Elaine L. Enger, MS

Download PDF: A Community Hospital-Based Congestive Heart Failure Program: Impact on Length of Stay, Admission and Readmission Rates, and Cost

Articles in this issue

about 27 years ago

Article

Safety and Efficacy of Metformin in a Restricted Formulary

about 27 years ago

Article

The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

about 27 years ago

Article

Medical Nutrition Therapy: A Powerful Tool in Disease Management

about 27 years ago

Article

Maintenance Drug Therapy of Chronic Obstructive Pulmonary Disease

about 27 years ago

Article

Correspondence regarding, "Compliance with Antihypertensive Therapy: Raising the Bar of Expectations"

about 27 years ago

Article

Obstacles to Early Discharge After Cardiac Surgery

about 27 years ago

Article

Integrating Healthcare for Older Populations

about 27 years ago

Article

Antibiotic Therapy of Helicobacter pylori Infection Reduces Healthcare Expenditures Related to Duodenal Ulcer

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

A Community Hospital-Based Congestive Heart Failure Program: Impact on Length of Stay, Admission and Readmission Rates, and Cost

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention